The new therapy is being hailed as a breakthrough. But the small study has some limitations – and hasn’t been peer-reviewed.
A new treatment for Huntington’s disease is genuinely promising – but here’s why we still need caution
Bryce Vissel, Cojoint Professor, School of Clinical Medicine, UNSW